Cargando…

Pseudotyping Improves the Yield of Functional SARS-CoV-2 Virus-like Particles (VLPs) as Tools for Vaccine and Therapeutic Development

Virus-like particles (VLPs) have been proposed as an attractive tool in SARS-CoV-2 vaccine development, both as (1) a vaccine candidate with high immunogenicity and low reactogenicity and (2) a substitute for live virus in functional and neutralization assays. Though multiple SARS-CoV-2 VLP designs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zak, Andrew J., Hoang, Trang, Yee, Christine M., Rizvi, Syed M., Prabhu, Ponnandy, Wen, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572262/ https://www.ncbi.nlm.nih.gov/pubmed/37834067 http://dx.doi.org/10.3390/ijms241914622

Ejemplares similares

114 VLPs and particle vaccines
por: Buonaguro, Luigi
Publicado: (2014)

Zika virus-like particles (VLPs) produced in insect cells
por: de Mello, Renata Gois, et al.
Publicado: (2023)

Protocol to evaluate the inflammatory response in human macrophages induced by SARS-CoV-2 spike-pseudotyped VLPs
por: Ouyang, Maggie Jing, et al.
Publicado: (2023)

Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs
por: Zepeda-Cervantes, Jesús, et al.
Publicado: (2020)

Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs)
por: Naupu, Paulina N., et al.
Publicado: (2020)

Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System
por: Mohsen, Mona O., et al.
Publicado: (2018)

The Adoption of Viral Capsid-Derived Virus-Like Particles (VLPs) for Disease Prevention and Treatments
por: Bogani, Giorgio, et al.
Publicado: (2020)

Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development
por: Pushko, Peter, et al.
Publicado: (2020)

RNA: packaged and protected by VLPs
por: Fang, Po-Yu, et al.
Publicado: (2018)

Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs
por: Kang, Hae-Ji, et al.
Publicado: (2019)

High immunogenicity of virus-like particles (VLPs) decorated with Aeromonas salmonicida VapA antigen in rainbow trout
por: Yang, Jeong In, et al.
Publicado: (2023)

Cell- Cell Transmission of VSV-G Pseudotyped Lentivector Particles
por: Skinner, Amy M., et al.
Publicado: (2013)

Cytokine Effects on the Entry of Filovirus Envelope Pseudotyped Virus-Like Particles into Primary Human Macrophages
por: Stantchev, Tzanko S., et al.
Publicado: (2019)

Packaging of actin into Ebola virus VLPs
por: Han, Ziying, et al.
Publicado: (2005)

Reliability of Pseudotyped Influenza Viral Particles in Neutralizing Antibody Detection
por: Yang, Jinghui, et al.
Publicado: (2014)

Functional RNAs: combined assembly and packaging in VLPs
por: Fang, Po-Yu, et al.
Publicado: (2017)

Expression and Characterization of Yeast Derived Chikungunya Virus Like Particles (CHIK-VLPs) and Its Evaluation as a Potential Vaccine Candidate
por: Saraswat, Shweta, et al.
Publicado: (2016)

SARS-CoV-2 Virus-like Particles (VLPs) Specifically Detect Humoral Immune Reactions in an ELISA-Based Platform
por: Hirschberg, Stefan, et al.
Publicado: (2022)

Photodynamic Therapy in Combination with the Hepatitis B Core Virus-like Particles (HBc VLPs) to Prime Anticancer Immunity for Colorectal Cancer Treatment
por: Hao, Yang, et al.
Publicado: (2022)

Trends on Human Norovirus Virus-like Particles (HuNoV-VLPs) and Strategies for the Construction of Infectious Viral Clones toward In Vitro Replication
por: Sion, Emilly, et al.
Publicado: (2023)

Structure-Based Design of Porcine Circovirus Type 2 Chimeric VLPs (cVLPs) Displays Foreign Peptides on the Capsid Surface
por: Wang, Dongliang, et al.
Publicado: (2018)

Comprehensive and systemic optimization for improving the yield of SARS-CoV-2 spike pseudotyped virus
por: Fu, Xinping, et al.
Publicado: (2020)

Production in yeast of pseudotype virus-like particles harboring functionally active antibody fragments neutralizing the cytolytic activity of vaginolysin
por: Pleckaityte, Milda, et al.
Publicado: (2011)

Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles
por: Moeschler, Sarah, et al.
Publicado: (2016)

Unique Aggregation of Retroviral Particles Pseudotyped with the Delta Variant SARS-CoV-2 Spike Protein
por: Petersen, Jennifer D., et al.
Publicado: (2022)

P10-10. HIV-1 Gag virus like particles pseudotyped with CD40 ligand to stimulate innate immune responses
por: Köstler, J, et al.
Publicado: (2009)

A Four-Step Purification Process for Gag VLPs: From Culture Supernatant to High-Purity Lyophilized Particles
por: González-Domínguez, Irene, et al.
Publicado: (2021)

Altering α-dystroglycan receptor affinity of LCMV pseudotyped lentivirus yields unique cell and tissue tropism
por: Dylla, Douglas E, et al.
Publicado: (2011)

Assembly of HCV E1 and E2 glycoproteins into coronavirus VLPs
por: Jourdan, N., et al.
Publicado: (2006)

Generation of MERS-CoV Pseudotyped Viral Particles for the Evaluation of Neutralizing Antibodies in Mammalian Sera
por: Almasaud, Abdulrahman, et al.
Publicado: (2019)

PreS1 Containing HBc VLPs for the Development of a Combined Therapeutic/Prophylactic Hepatitis B Vaccine
por: Dishlers, Andris, et al.
Publicado: (2023)

Abrogation of contaminating RNA activity in HIV-1 Gag VLPs
por: Valley-Omar, Ziyaad, et al.
Publicado: (2011)

Production of Brazilian human norovirus VLPs and comparison of purification methods
por: Lamounier, Thais Alves da Costa, et al.
Publicado: (2015)

Construction of HER2-Specific HIV-1-Based VLPs
por: Martins, Sofia A., et al.
Publicado: (2022)

Visualizing fusion of pseudotyped HIV-1 particles in real time by live cell microscopy
por: Koch, Peter, et al.
Publicado: (2009)

Immunogenicity of Wild Type and Mutant Hepatitis B Surface Antigen Virus-like Particles (VLPs) in Mice with Pre-Existing Immunity against the Wild Type Vector
por: Kingston, Natalie J., et al.
Publicado: (2023)

Dissolving Microneedles Loaded with Nanoparticle Formulation of Respiratory Syncytial Virus Fusion Protein Virus-like Particles (F-VLPs) Elicits Cellular and Humoral Immune Responses
por: Menon, Ipshita, et al.
Publicado: (2023)

The Delta variant SARS-CoV-2 spike protein uniquely promotes aggregation of pseudotyped viral particles
por: Petersen, Jennifer D., et al.
Publicado: (2022)

Establishment of Baculovirus-Expressed VLPs Induced Syncytial Formation Assay for Flavivirus Antiviral Screening
por: Dai, Shiyu, et al.
Publicado: (2018)

Pseudotyping retrovirus like particles vaccine candidates with Hepatitis C virus envelope protein E2 requires the cellular expression of CD81
por: Soares, Hugo R., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_aduoepoh5pdle38ftt4tvp5v05